Key result
Multi-target antihypertensive peptides offer better BP control and lower resistance risk versus single-target peptides.
Why the study?
Traditional antihypertensive drugs cause side effects and most existing peptides target single pathways, limiting their effectiveness against the complex mechanisms of hypertension.
This narrative review outlines the potential of food-derived multi-target antihypertensive peptides and AI-driven screening methods for developing novel hypertension therapies.
May offer advantages over single-target agents in hypertension; leaves open confirmation via randomized trials before clinical use.
Hypertension is a major global public health challenge. Traditional antihypertensive drugs often cause side effects, which has prompted growing interest in natural antihypertensive agents. However, most existing antihypertensive peptides target single pathways, thereby constraining their effectiveness against hypertension’s complex mechanisms. In contrast, multi-target peptides modulate complex hypertension-related networks, offering enhanced blood pressure control and reduced resistance risks. This narrative review comprehensively summarizes the latest research progress on multi-target antihypertensive peptides, including their main food sources (animal, plant, and microorganism sources) and bioactive mechanisms. In addition, this review also describes the process of artificial intelligence (AI) and network pharmacology-driven multi-target antihypertensive peptide screening, and summarizes the machine learning (ML) models and activity prediction websites that have been applied to antihypertensive peptide screening. Finally, this review explores the challenges and future directions in multi-target antihypertensive peptide research, thereby providing a theoretical basis for the development of novel multi-target antihypertensive peptides.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a review in Hypertension. Multi-target antihypertensive peptides vs. Single-target antihypertensive peptides was evaluated. Multi-target antihypertensive peptides modulate complex hypertension-related networks, offering enhanced blood pressure control and reduced resistance risks compared to single-target peptides.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: